These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
697 related items for PubMed ID: 15891959
21. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E. Clin Endocrinol (Oxf); 2005 Dec; 63(6):642-9. PubMed ID: 16343098 [Abstract] [Full Text] [Related]
22. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Sereg M, Toke J, Patócs A, Varga I, Igaz P, Szücs N, Horányi J, Pusztai P, Czirják S, Gláz E, Rácz K, Tóth M. Steroids; 2011 Jan; 76(1-2):38-42. PubMed ID: 20813120 [Abstract] [Full Text] [Related]
23. Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome. Sakihara S, Kageyama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nigawara T, Hirata Y, Hashimoto K, Suda T. Endocr J; 2010 Jan; 57(4):331-7. PubMed ID: 20139634 [Abstract] [Full Text] [Related]
24. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan. Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y. Endocr J; 2008 Mar; 55(1):121-6. PubMed ID: 18202529 [Abstract] [Full Text] [Related]
25. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup. Friedman TC, Zuckerbraun E, Lee ML, Kabil MS, Shahinian H. Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763 [Abstract] [Full Text] [Related]
26. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B. Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [Abstract] [Full Text] [Related]
27. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome. Ng CM, Lam TK, Au Yeung YC, Choi CH, Iu YP, Shek CC, Tiu SC. Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058 [Abstract] [Full Text] [Related]
28. Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes? Ellis E, Chin PK, Hunt PJ, Lunt H, Lewis JG, Soule SG. N Z Med J; 2012 Apr 20; 125(1353):47-58. PubMed ID: 22522271 [Abstract] [Full Text] [Related]
30. Distinct Late-Night Salivary Cortisol Cut-Off Values for the Diagnosis of Hypercortisolism. van Baal L, Wichert M, Zwanziger D, Dralle H, Weber F, Kreitschmann-Andermahr I, Führer D, Unger N. Horm Metab Res; 2021 Oct 20; 53(10):662-671. PubMed ID: 34607366 [Abstract] [Full Text] [Related]
31. Midnight serum cortisol: comparison of healthy volunteers and hospitalized patients with Cushing's syndrome. Pikkarainen L, Alfthan H, Markkanen H, Sane T. Scand J Clin Lab Invest; 2002 Oct 20; 62(5):357-60. PubMed ID: 12387581 [Abstract] [Full Text] [Related]
32. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test. Marcus-Perlman Y, Tordjman K, Greenman Y, Limor R, Shenkerman G, Osher E, Stern N. Clin Endocrinol (Oxf); 2006 Feb 20; 64(2):215-8. PubMed ID: 16430723 [Abstract] [Full Text] [Related]
33. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, Mann K, Petersenn S. Eur J Endocrinol; 2012 Apr 20; 166(4):613-8. PubMed ID: 22214924 [Abstract] [Full Text] [Related]
34. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC. J Clin Endocrinol Metab; 1999 Mar 20; 84(3):878-82. PubMed ID: 10084565 [Abstract] [Full Text] [Related]
35. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome. Kuzu I, Zuhur SS, Demir N, Aktas G, Yener Ozturk F, Altuntas Y. Endokrynol Pol; 2016 Mar 20; 67(5):487-492. PubMed ID: 26884297 [Abstract] [Full Text] [Related]
36. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome. Bruno OD, Rossi MA, Juárez-Allen L, Serra HA, Albiero MC. Medicina (B Aires); 2015 Mar 20; 75(6):373-8. PubMed ID: 26707659 [Abstract] [Full Text] [Related]
37. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F. Clin Endocrinol (Oxf); 2007 Feb 20; 66(2):251-7. PubMed ID: 17223996 [Abstract] [Full Text] [Related]
38. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM. Clin Endocrinol (Oxf); 2004 Dec 20; 61(6):675-82. PubMed ID: 15579180 [Abstract] [Full Text] [Related]
39. Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population. Aberle J, Schulze Zur Wiesch C, Flitsch J, Veigel J, Schön G, Jung R, Reining F, Lautenbach A, Rotermund R, Riedel N. J Endocrinol Invest; 2018 Nov 20; 41(11):1325-1331. PubMed ID: 29550934 [Abstract] [Full Text] [Related]